You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國先鋒醫藥(01345.HK)中期股東應占溢利跌68.81%至3076.7萬元 每股派0.071港元
格隆匯 08-28 20:13

格隆匯 8 月 28日丨中國先鋒醫藥(01345.HK)公佈,截至2020年6月30日止6個月,公司收益為人民幣6.23億元,同比增長0.4%;毛利為人民幣2.52億元,同比減少17.5%;公司擁有人應占期內溢利為人民幣3076.7萬元,同比減少68.81%;每股基本盈利為人民幣0.03元,擬派中期息每股0.071港元。

期內溢利為人民幣3040萬元,同比減少69.1%,主要由於公司個人防護用品新業務的毛利率較低,不足以彌補因疫情原因所減少的醫藥產品毛利損失,同時,報告期所得税開支同比增加人民幣2430萬元,聯營公司權益減值撥回(虧損)較上年同期也減少了人民幣2670萬元。集團的純利率由截至2019年6月30日止六個月的15.8%減少至報告期內的4.9%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account